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Abstract
Transmission from pet rats and cats to humans as well as severe infection in felids and other animal species have
recently drawn increasing attention to cowpox virus (CPXV). We report the cloning of the entire genome of
cowpox virus strain Brighton Red (BR) as a bacterial artificial chromosome (BAC) in Escherichia coli and the recovery
of infectious virus from cloned DNA. Generation of a full-length CPXV DNA clone was achieved by first introducing
a mini-F vector, which allows maintenance of large circular DNA in E. coli, into the thymidine kinase locus of CPXV
by homologous recombination. Circular replication intermediates were then electroporated into E. coli DH10B cells.
Upon successful establishment of the infectious BR clone, we modified the full-length clone such that
recombination-mediated excision of bacterial sequences can occur upon transfection in eukaryotic cells. This self-
excision of the bacterial replicon is made possible by a sequence duplication within mini-F sequences and allows
recovery of recombinant virus progeny without remaining marker or vector sequences. The in vitro growth
properties of viruses derived from both BAC clones were determined and found to be virtually indistinguishable
from those of parental, wild-type BR. Finally, the complete genomic sequence of the infectious clone was
determined and the cloned viral genome was shown to be identical to that of the parental virus. In summary, the
generated infectious clone will greatly facilitate studies on individual genes and pathogenesis of CPXV. Moreover,
the vector potential of CPXV can now be more systematically explored using this newly generated tool.
Introduction
Cowpox virus (CPXV) belongs to the family Poxviridae,
a family of large double- stranded DNA viruses replicat-
ing in the cytoplasm. It is endemic in Eurasia and
reportedly transmitted from rodents as the reservoir
host to other mammals. CPXV causes disease in felids,
zoo animals, man and, despite its name, only very rarely
in cattle. Not only recent outbreaks in humans but also
its close relationship to other important members of the
genus such as variola virus have drawn attention to this
virus as a model, especially regarding its impressive abil-
ities to evade host immunity [1-3].
Bacterial artificial chromosomes (BAC), first published
by Shizuya et al. in 1992 [4], allow the stable mainte-
nance of large plasmids of up to 300 kbp in size at low
copy numbers in Escherichia coli.T h eg e n o m eo fa
herpesvirus, human cytomegalovirus (HCMV), was the
first full-length viral genome cloned as a BAC in 1997
[5]. Infectious genomes cloned as BAC have proven a
useful tool in molecular virology, both for investigations
into viral pathogenesis as well as for applications in
vaccination and gene therapy, because mutations can be
introduced with ease using recombination or transposon
systems of E. coli [6].
With respect to poxviruses, the cloning and successful
recovery of infectious BAC was published for vaccinia
virus strains Western Reserve [7,8] and for modified
vaccinia virus Ankara (MVA), an attenuated vaccinia
virus strain that is replication-deficient in most cell
types [9]. Here, we show the generation and characteri-
zation of the first infectious clone of a cowpox virus
that contains the complete genome of CPXV strain
Brighton Red (BR). The BAC allows the application of
bacterial mutagenesis procedures including minimal
modifications and markerless approaches. With the help
of the transcriptional machinery of fowlpox virus
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culture. Since it is desirable to avoid any foreign
sequences in reconstituted viruses, we modified the par-
ental CPXV BAC into a self-excisable construct by
introducing a duplication of flanking sequences in inverse
orientation into the mini-F cassette, an approach that was
previously shown for infectious herpesvirus and poxvirus
genomes [10]. Self-excision of mini-F sequences was effi-
cient upon reconstitution in eukaryotic cells and virus
progeny derived from cloned genomes therefore is
genetically and phenotypically indistinguishable from
parental CPXV BR.
Materials and methods
Cell lines and viruses
African green monkey Vero 76 cells (Collection of Cell
Lines in Veterinary Medicine, Friedrich-Loeffler Insti-
tute, Greifswald-Insel Riems, Germany) were kept in
Eagle’s minimal essential medium (MEM, Biochrom,
Berlin, Germany) supplemented with 5-10% fetal bovine
serum (FBS, Biochrom). Primary chicken embryo cells
(CEC) were prepared from 11-day-old embryos accord-
ing to standard procedures and cultured in MEM con-
taining 10% FBS [11].
CPXV strain Brighton Red (AF428758), kindly pro-
vided by Dr Philippa Beard, University of Edinburgh,
UK, was propagated on Vero cells and FWPV (Nobilis-
PD, strain WP, Intervet, Boxmeer, The Netherlands;
kindly provided by Dr D. Lüschow, Freie Universität
Berlin, Germany), on CEC.
Bacteria and plasmid constructs
Plasmids for generation of the CPXV BAC pBRf
The pBeloBAC11-derived mini-F construct was kindly
provided by Dr M. Cottingham, Jenner Institute Oxford,
UK. For construction of the transfer plasmid used for the
generation of recombinant thymidine kinase (TK)-nega-
tive CPXV (BR.TK-), the nonessential TK gene (BR 106)
was amplified with primers #46 and #47 (Table 1) and
initially cloned into pCRII (Invitrogen, Darmstadt,
Germany) (plasmid #5). An inverse PCR, using primers
oligonucleotides #48 and #49, led to the introduction of
an FseI restriction site located centrally within the TK
gene after religation (plasmid #6). An FseI restriction frag-
ment of the pBeloBAC11 derivate, containing the mini-F
cassette with the chloramphenicol resistence gene (cat),
loxP sites and the green fluorescent protein gene (gfp)
under the control of the late FWPV promoter p4B [9], was
ligated into the single FseI restriction site of plasmid #6.
Colonies containing the resulting, complete transfer plas-
mid (plasmid #7) were selected for their triple resistance
to ampicillin, kanamycin and chloramphenicol.
Plasmids for generation of self-excisable CPXV BAC pBR
The transfer plasmid for in t r o d u c t i o no fa ni n v e r s e
duplication of the TK flanks into the mini-F sequence
present in full-length CPXV.BR BAC (pBRf) was based
on plasmid pEPMCS-in-Belo as described previously
[10]. The transfer construct contains mini-F-derived
sequence flanks A and B of approximately 830 bp in
length as well as the kanamycin resistance gene aphAI
with an adjoining I-SceI restriction site. The aphAI-I-
SceI cassette is flanked by duplication sequences utilized
for E. coli recombineering, I-CeuI restriction sites frame
the complete construct. The TK fragment was cut out
of plasmid #5 using BamHIa n dPstI restriction sites
and ligated into the multiple cloning site of pEPMCS-in-
Belo (plasmid #10). The duplication was inserted into
the mini-F cassette in inverse orientation relative to ori-
ginal viral sequences in pBRf.
Bacteria and transformation
Regular plasmids were grown and maintained in E. coli
Top10 cells (Invitrogen). For generation of an infectious
CPXV full length clone, pBRf, electrocompetent E. coli
DH10B cells (MegaX, Invitrogen) were electroporated
with viral DNA at 1300 V and 100 Ω resistance (Biorad,
München, Germany). For generation of pBR, two-step Red
recombination was applied after transfer of pBR into
E. coli GS1783 cells [12]. All recombination procedures
Table 1 Primers used in this study
Oligo # Sequence 5’-3’ Comments
oligo #046 forward TCCTTAATTAAGACAACTCAAACATCTGCGTTATC
oligo #047 reverse TCCTTAATTAAGCAGTACTAGGTTCATTTCCTCCT
oligo #048 forward TTTAAAGGCCGGCCACAGTTCTTTCCAGACATTGTTGA FseI site underlined
oligo #049 reverse TTTAAAGGCCGGCCTTCATCGATACCTATCACGG FseI site underlined
oligo #237 forward GAGCCCACGTTTAAACATTCTT
oligo #238 reverse GGTAACATAATACCCTTTTCCTGAA mini-F
oligo #239 forward TCGTATGTTGTGTGGAATTGTGA mini-F
oligo #240 reverse ACCGTGTGGAATATAAAAGTCCT
oligo #264 reverse CGATAATAGATACGGAACGGGAC TK
oligo #265 forward TTACGTTGAAATGTCCCATCAA TK
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exactly as described previously [13].
Preparation of viral and plasmid DNA, restriction
fragment length polymorphism (RFLP) analysis and
Southern blotting
Viral DNA for electroporation and generation of pBRf
was isolated from cells infected with BR.TK- after addi-
tion of 100 μMI bT (isatin-b-thiosemicarbazone,
Chemos GmbH, Regenstauf, Germany) at 3 h post infec-
tion (pi). Cells were harvested by scraping at 48 h pi and
the cell pellet was incubated in lysis buffer (0.02 M Tris
HCl (pH 8.0); 0.01 M EDTA; 0.75% SDS; 0.65 mg/mL
proteinase K) at 55°C for 5 h. Nucleic acids were
extracted by addition of supersaturated NaCl to a final
concentration of 2 M and precipitated with isopropanol
(final concentration: 50%). The same procedure without
addition of IbT was followed for the extraction of viral
DNA for PCR analysis and determination of restriction
fragment length polymorphisms (RFLP).
Plasmid or BAC DNA for cloning and standard appli-
cations such as restriction enzyme digests was extracted
by the alkaline lysis method, variably including or omit-
ting phase separation and removal of cellular debris
with phenol-chloroform [14]. For whole genome
sequencing, large scale BAC DNA purifications were
carried out using the plasmid midi kit (Qiagen, Hilden,
Germany) following the manufacturer’s instructions. For
determination of RFLP, DNA cut with various restric-
tion enzymes was separated by electrophoresis for 14 h
at 35 V in 0.8% agarose gels using 1× TAE buffer (40
m MT r i s ;2 0m Ma c e t i ca c i d ;1m ME D T A ;5 0 ×T A E
sock solution pH 8.4).
Southern blotting with a digoxigenin (DIG) labeled TK
PCR probe was done using the DIG PCR Labeling Kit
and the DIG Nucleic Acid Detection Kit (Roche, Man-
nheim, Germany) exactly following the manufacturer’s
instructions.
Reconstitution of infectious virus
Transfections for the generation of recombinant virus as
well as for recovery of virus from BAC DNA were car-
ried out with approximately 2 μg of purified plasmid or
BAC DNA and 4 μL FuGene (Roche) according to
the manufacturer’s instructions. For virus reconstitution,
1×1 0
6 Vero cells seeded in one well of a 6-well plate
were infected with 100-1 000 plaque-forming units (pfu)
of FWPV at 1 to 5 h before or after transfection.
Pyrosequencing
A DNA library for sequencing with Genome Sequencer
FLX (Roche) was prepared from enriched and purified
BAC DNA according to an established protocol [15].
The resulting dsDNA library was then bound to library
capture beads and, subsequently, a single-stranded tem-
plate DNA (ssDNA) library was recovered. The ssDNA
library was prepared for sequencing and sequenced
according to the manufacturer’s instructions. The
obtained raw sequence data were assembled using the
GS assembler software Newbler (v. 2.0.00.22; Roche).
Assembled contigs were further analyzed with
VectorNTI Advance 11 (Invitrogen).
Characterization of virus growth properties
Single- and multi-step growth kinetics of reconstituted
viruses were carried out on Vero cells using multiplici-
ties of infection (MOI) of 3 or 0.01, respectively. Cells
were infected, washed three times with PBS 90 min after
infection, and supplied with 1 mL of fresh cell culture
medium. The 0 h time point was taken immediately
after addition of new medium. Cell culture supernatant
was harvested, subjected to low-speed centrifugation
(8 min, 6 000 × g) to remove cells and cellular debris,
and 1 mL of fresh medium per well were added. Both
the cellular fraction and cleared supernatants were trea-
ted by freezing (-70°C) and thawing (37°C) three times
before centrifugation and followed by quantification in
plaque assays.
End point titers were determined in a similar manner.
Virus was added to cells at an MOI of 3, 0.1 or 0.01,
and cells were harvested at 24, 48 and 72 h after the
washing procedure that was done 90 min after addition
of virus as described above.
For plaque size determinations, 1 × 10
6 Vero cells
were infected with 100 pfu per well of a 6-well plate
and overlaid 90 min pi with carboxymethyl cellulose
(CMC, final concentration: 0.8% in MEM with 3.5%
FBS). Plaque images were taken at 48 h pi using the
Zeiss Axiovert 25 (Carl Zeiss, Jena, Germany) equipped
with a CCD camera (AxioCam MRm, Zeiss), processed
with the Axiovision software (Zeiss), and analyzed using
ImageJ software http://rsb.info.nih.gov/ij/. Statistical ana-
lyses of virus growth kinetics and plaque areas were
done using the Student’s t-test http://www.graphpad.
com.
Results
Generation of recombinant CPXV BR.TK- harboring mini-F
vector sequences
Vero cells infected with CPXV strain BR were trans-
fected with transfer plasmid #7 (Figure 1A) at 3 h pi.
Plaque picking and passaging of end-point dilutions of
recombinant progeny virus identified by GFP expression
were carried out in an alternating fashion. Pure recom-
binant BR.TK-, which carries mini-F sequences from
modified pBeloBAC11 inserted within TK-encoding
sequences, was obtained after 8 cycles of plaque and
end-point purification (Figure 1B).
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Figure 1 Schematic presentation of rationale for cloning of cowpox virus infectious clone. A. Shown is a schematic of the full-length
CPXV.BR genome and the TK locus in greater detail. In a first step, the viral TK was amplified by PCR, cloned into the pCRII vector, which was
then used for an inverse PCR to introduce an FseI restriction site into TK. Mini-F vector sequences containing gfp under the control of the late 4B
promoter were finally inserted into the singular FseI site to obtain transfer plasmid #7. B. Shown are the constructs and the strategy used to
obtain recombinant virus BR.TK- and the full-length CPXV.BR BAC pBRf. Recombinant BR.TK- was used to infect Vero cells. Infection resulted in
the formation of replication intermediates, concatemers, some of which were circularized. Viral DNA extracted from cells infected with BR.TK- was
electroporated into E. coli DH10B giving rise to pBRf. The full-length CPXV BAC clone was ultimately transfected into Vero cells using FWPV as a
helper. Scale bars indicate the sizes of the molecules. Abbreviations: ITR, inverted terminal repeats; cat, chloramphenicol resistance gene; gfp,
green fluorescent protein gene: loxP, loxP sites; H, “head”,T ,“tail” orientation of the ITR present in the replicative intermediates.
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(pBRf) and reconstitution of recombinant virus (vBRf)
from cloned DNA
The sequence of manipulations resulting in the genera-
tion of a full-length CPXV infectious clone, including the
cloning strategy and the mini-F vector recombination
into the viral genome, are illustrated in Figure 1. Vero
cells were infected with recombinant virus BR.TK- and
supplemented with IbT in order to accumulate unre-
solved concatemeric replication intermediates through
the interference of the drug with late transcription
[16,17] (Figure 1B). Among the accumulated concate-
mers, the small fraction of desired head-to-tail concate-
mers was increased accordingly. Only head-to-tail
concatemers can harbor complete CPXV genomes and
the mini-F sequence in the same orientation. Conse-
quently, the likelihood of homologous recombination of
sequences with identical orientation within head-to-tail
concatemeric DNA is higher and can lead to circulariza-
tion of the full-length genome. Viral DNA was electropo-
rated into electrocompetent E. coli DH10B cells and the
full-length CPXV BAC, pBRf, was obtained (Figure 1B).
Restriction enzyme digestion and RFLP analysis using 7
different enzymes proved establishment and faithful
maintenance of the complete CPXV genome as a low-
copy BAC in E. coli.T h eR F L P ’s obtained for pBRf after
digestion and 0.8% agarose gel electrophoresis using
HindIII, KpnI, PstI, SacI, SphI, StuI and XhoI exactly
matched those from in silico predictions (Figure 2).
After confirming the integrity of the full-length pBRf
clone, virus was successfully reconstituted from DNA
using FWPV as helper virus. BAC DNA was transfected
into 1 × 10
6 Vero cells that were infected with 100-1
000 PFU of FWPV several hours before or after infec-
tion. Formation of GFP-expressing virus plaques showed
that virus derived from pBRf, termed vBRf, was fully
replication-competent. Integrity of the complete vBRf
genome including the mini-F sequences was proven by
demonstration of the expected restriction fragment
patterns and Southern blot analysis (see below). We
therefore concluded that the complete CPXV.BR gen-
ome was successfully established in E. coli and that fully
replication-competent CPXV was reconstituted from
viral DNA cloned as a BAC.
 
Figure 2 Restriction fragment analysis of full-length BAC clone pBRf. A. BAC DNA was isolated and digested with seven different enzymes
(HindIII, KpnI, PstI, SacI, SphI, StuI, XhoI) and separated on a 0.8% agarose gel. Sizes of a molecular weight marker (generuler 1-kb plus DNA
ladder, Fermentas) are given. B. Patterns corresponded exactly to the predictions based on the complete CPXV.BR genome (#NC_003663) as
shown by in silico digests using VectorNTI.
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generation of recombinant vBR virus
In order to construct a CPXV BAC that would allow
self-excision of the mini-F vector sequences upon virus
reconstitution in eukaryotic cells, the full-length pBRf
BAC was transferred into recombination-competent E.
coli GS1783 cells [12]. Using markerless two-step Red
recombination [13], an inverse duplication of TK
sequences identical to the viral sequence flanks on
either side of the inserted mini-F sequences present in
pBRf was introduced within the mini-F cassette itself.
To achieve this introduction, transfer plasmid
pEPMCS_TK (plasmid #10) was digested with I-CeuI
and the resulting fragment (Figure 3A) was electropo-
rated into recombination competent GS1783 harboring
pBRf. In a first Red recombination, the TK sequences,
together with aphAI and an I-SceI site immediately
adjoining the resistance gene and short flanking
sequences, were introduced into the mini-F sequences
of pBRf. Recombination occurred between homologous
sequences present within the mini-F (Figure 3B). Result-
ing colonies were screened for resistance against kana-
mycin and chloramphenicol and BAC DNA from
double-resistant colonies was extracted and examined
by RFLP. Colonies with BAC RFLP patterns matching
those for the predicted cointegrates were resolved, tak-
ing advantage of the homing endonuclease I-SceIs i t e
located upstream of the aphAI. Cleavage at the site
induces a double strand break resulting in excision of
the resistance gene by homologous recombination
between duplication of sequences up- and downstream
of the aphAI-I-SceI casette in a second recombination
event [13]. After induction of I-SceI cleavage, resulting
colonies were screened for the loss of kanamycin resis-
tance and the final construct, termed pBR, was analyzed
by RFLP and compared to the restriction enzyme pat-
tern of the parental pBRf BAC. Comparison of restric-
tion enzyme profiles obtained for SphI, SacI and XhoI
confirmed successful integration of the duplicated
sequences within the mini-F vector sequences (Figure 4).
Insertion of the duplication of TK sequences led to an
additional 6.3 kbp band, enlargement of a 17.9 kbp to a
19.6 kbp band, and the appearance of a 4.7 kbp band,
respectively (Figure 4). Successful insertion was also pro-
ven by Southern blot analysis using a TK probe, which
demonstrated the presence of the additional TK
sequences. In the SphI digest, the 37.8 kbp band in pBRf
is reduced in size to a 33.2 kbp band, whilst the 11.9 kbp
band is consistently present in both pBRf and pBR as pre-
dicted (Figure 4). In the case of SacI digested DNA, the
36.5 kbp band present in pBRf is also present in pBR,
whereas the 17.9 kbp band is enlarged and 19.6 kbp in
size in pBR (Figure 4). A very clear difference is seen in
the XhoI patterns of pBRf and pBR, where a 3 kbp band
increases in size to 4.7 kbp following insertion of the TK
duplication (Figure 4). From the results we concluded
that the TK duplication was correctly inserted into the
pBRf, which was further verified by DNA sequencing of
the modified mini-F vector sequences in pBR (data not
shown).
Vero cells were transfected with pBR, and upon recon-
stitution using FWPV as a helper, non-fluorescent
plaques, indicative of the loss of the mini-F plasmid as
GFP expression was absent, were already observed in
the first passage after transfection (Figure 5). After three
passages, a homogenous virus population was obtained
in which none of the virus plaques examined showed
GFP fluorescence. Virus progeny from those plaques
was thus suspected to have lost mini-F sequences
through a recombination event mediated by the inverse
TK duplication. Bacterial and virus DNA was therefore
digested with XhoI (Figure 5) or KpnI (data not shown)
and RFLP and Southern blotting were performed. In
both RFLP and Southern blot analyses, DNA obtained
from vBR-infected cells and cells infected with parental
wild-type BR showed the same pattern, which indicated
the overall similarity of nucleotide sequences of virus
o b t a i n e df r o mc l o n e dD N Aa n dt h eo r i g i n a lC P X V .
Absence of residual vector sequences was finally con-
firmed by PCR targeting the mini-F and TK loci with
primer pairs either targeting TK sequences or both
mini-F and TK sequences. Presence of mini-F sequences
was readily detectable by PCR in vBRf obtained after
reconstitution from pBRf (Figure 6). In contrast, DNA
obtained from cells infected with recombinant vBR virus
or wild-type virus BR lacked the corresponding bands
and instead specified bands following PCR amplification
targeting sequences at both the extreme 5’ and 3’ end of
the TK gene (Figure 6). From the results of the RFLP
patterns and the PCR we concluded that mini-F
sequences were indeed completely absent in virus pro-
geny reconstituted from pBR and was therefore indistin-
guishable from parental CPXV.BR.
Nucleotide sequence of pBR
Results from RFLP’s and the following Southern blot
analysis were consistent with the predicted restriction
enzyme fragment patterns, and sizes of restriction frag-
ments of pBRf, vBRf, pBR and vBR were identical to
those present in CPXV.BR or were fully consistent with
the introduced sequences (pBRf, vBRf, pBR, Figures. 2, 4
and 5). To further evaluate the integrity of the generated
infectious clones, whole genome sequencing of pBR and
comparison with the published CPXV.BR sequence
(accession #NC_003663) was performed. pBR DNA was
purified and subjected to pyrosequencing. Assembly of
the contigs revealed only very few mismatches and
changes when compared to the published sequences.
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Figure 3 Schematic of the modification of pBRf to arrive at a self-excisable construct (pBR). A. The TK sequences present in plasmid #5
were inserted into plasmid pEPMCS-in-Belo containing flanks A and B homologous to sequences within in the mini-F vector present in pBRf as
well as an I-SceI site and aphAI, which confers resistance to kanamycin, resulting in plasmid #10. B. The construct was then integrated into the
mini-F sequence of pBRf in inverse orientation via en passant mutagenesis. After transfection of the generated construct in eukaryotic cells,
vector sequences are lost through two antiparallel recombination events, which are indicated by the cross-over lines.
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either end of the pBR genome that contain highly repe-
titive, noncoding sequences needed for viral DNA
amplification during the virus replication cycle [18]. The
sequences are known to be highly variable, but were
s h o w nt ob ef u n c t i o n a la sp r o v e nb yt h ef a c tt h a tw e
were able to reconstitute virus de novo from the infec-
tious clone. We then targeted the differences between
the determined pBR and published CPXV.BR sequence
as well as regions in the nucleotide sequence that had
remained ambiguous after pyrosequencing. Regions with
unresolved ambiguities were amplified by PCR and
sequenced by standard chain termination protocols
according to Sanger (StarSeq, Mainz, Germany). We dis-
covered that sequence changes were caused by pyrose-
quencing errors in the majority of the cases. However,
we identified a total of 7 remaining non-silent sequence
variations in pBRf when compared to the published
sequence (Table 2). Those regions were then analyzed
by PCR amplification and sequencing of the corre-
sponding regions of parental DNA derived from
CPXV.BR used for the generation of the BAC. Com-
parison of the aligned sequences of CPXV.BR and pBR
revealed that the sequences of the infectious BAC
clone did not differ from that of the original virus but
only from the Genbank reference sequence (Table 2)
with the exception of two silent nucleotide changes in
the TK locus that were introduced by the initial PCR
for cloning of the flanking regions for introduction of
the mini-F vector. As codon usage was not affected by
the two nucleotide exchanges and as the nucleotide
substitutions can possibly be used for genetic identifi-
cation of BAC-derived viruses, we refrained from
repairing the PCR errors. We find it remarkable that
only a total of 7 nucleotide differences between the
pBR and the published CPXV.BR were identified and
are unable to determine the reason for the changes at
the present time. However, it is likely that passaging of
A       B 
      
Figure 4 Restriction fragment analysis of of pBR and pBRf. A. BAC DNA was digested with SphI, SacI or XhoI and fragments separated by
0.8% agarose gel electrophoresis. Changes of the restriction pattern due to the inserted TK duplication are marked with a box. Sizes of a
molecular weight marker (generuler 1-kb plus DNA ladder, Fermentas) are given. B. Southern blot analysis after transfer of the gel shown in (A)
and using a TK DIG labeled probe. The expected sizes of the fragments were identified (see text). Sizes of a molecular weight marker (generuler
1-kb plus DNA ladder, Fermentas) are given.
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larly as affected genes are exclusively genes involved in
immunomodulation and in vivo host range determina-
tion for which evolutionary pressure is absent under
the condition of propagation in cultured cells [19].
Phenotypic characterization of recombinant CPXV.BR
derived from pBRf or pBR
In the final set of experiments, we determined the
growth characteristics of the viruses generated from
infectious clones in comparison with parental CPXV.BR.
A        B  
    
C 
 
 
 
Figure 5 RFLP analysis of pBR- and pBRf-derived viruses and characterization of mini-F loss in pBR-derived viruses. A. BAC DNA or viral
DNA prepared from infected Vero cells was digested with XhoI and separated by 0.8% agarose gel electrophoresis. The lanes contain the DNA’s
from BAC DNA (pBRf, pBR), viruses reconstituted from cloned DNA (vBRf, vBR) or parental CPXV.BR DNA (BR). Changes of the restriction pattern
due to the presence and therefore disruption of TK of absence of mini-F sequences are marked with boxes (see text). B. Southern blot analysis
after transfer of the gel shown in (A) and using a DIG labeled TK probe. The changes seen with a DIG labeled TK probe show the expected
changes due to the disruption of TK with mini-F sequences (pBRf, vBRf), the introduction of an inverse TK sequence (pBR), and the loss of any
bacterial sequences in vBR (see text). Sizes of a molecular weight marker (generuler 1-kb plus DNA ladder, Fermentas) are given. C. Development
of GFP fluorescence in plaques following removal of mini-F sequences. Initially, all plaques exhibit GFP fluorescence (plaque in left panels), which
is then partially lost (plaque in middle panels) or completely absent (plaque in right panels). Identical plaques were photographed under
fluorescent light (upper panels) or using phase contrast (lower panels) with a Zeiss Axiovert microscope and a CCD camera (Zeiss).
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reconstituted from infectious did not differ significantly
from those of CPXV.BR. Single-step growth kinetics
performed by infecting Vero cells at an MOI of 3
revealed that both BAC-derived viruses, vBRf and vBR,
reached extracellular virus titers between 1 000 and 100
000 pfu/mL and cell-associated virus titers between 100
000 and 1 000 000 pfu/mL at 48 h pi. Titers at all time
points after infection were virtually indistinguishable
from those of parental CPXV.BR (Figure 7). Similarly,
multi-step growth kinetics performed by infection of
Vero cells at an MOI of 0.1 with the various viruses did
Figure 6 PCR analysis for verification of presence of mini-F sequences in CPXV.BR, vBRf or vBR. DNA isolated from cells infected with
CPXV.BR, vBRf or vBR was subjected to PCR targeting TK and the mini-F vector. Lanes 1 and 2 contain PCR amplicons using primer pairs #237
+#265 or #264+#240, respectively, which target full-length TK. Bands at sizes of 1,126 bp or 1,054 bp, respectively, are obtained in the case that
mini-F sequences are absent in the DNA analyzed. Lanes 3 and 4 using primer pairs #264+#238 or #239+#265) only yield a PCR product in the
case that the mini-F sequence is still present and result in bands of 324 bp and 210 bp, respectively. Gel images for the individual virus DNAs
are shown and the size of a molecular weight marker (generuler 1-kb plus DNA ladder, Fermentas) are given.
Table 2 List of nucleotide sequence differences of CPXV.BR and cloned pBR when compared to the published BR
sequence
A. Changes in coding sequences
Gene (according to
NC_003663)
Function Modification (nt
position)
Present in
parental virus
Effect
006 ankyrin
a C to A (5 038) no silent
019 ankyrin C to T (21 015) yes Glu to Lys, not in ankyrin repeats
035 kelch-like ins. T (36 656) yes split protein, resembles situation in other
orthopox viruses
079 glutaredoxin (GRX) family C to T (76 314) yes Asp to Asn, polymorphic region of the protein
089 protein G1 (Peptidase) T to C (87 650) yes Asn to Asp, like in 91-3
105 tk T to C (97 522) no silent, PCR error
106 polyA polymerase small SU (105 299) no silent, PCR error
139 poxvirus early transcription
factor (VETF)
Insertion : T (142
924)
yes C-terminal amino acid sequence changed from
RAQIN to KSTNKLNN
193 kelch-like C to T (189 440) yes Ser to Phe, polymorphic region of the protein
215 kelch-like C to T (213 275) yes Pro to Ser, polymorphic region of the protein
225 ankyrin
a G to T (229 788) no silent
B. Changes in non-coding sequences
Modification (nt position) Comment
Insertion : TG (8 899-8 900)
b poly-TG repeat, polymorphic in viral DNA
C to T (58 974)
Insertion : T (65 922) poly-T stretch
Insertion : CA (225 926-225 927)
b poly-CA repeat, polymorphic in viral DNA
Insertion : TG (8 899-8 900)
b poly-TG repeat, polymorphic in viral DNA
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either, and titers recorded for vBRf, vBR and CPXV.BR
were highly similar in the case of both extracellular and
cell-associated virus titers (Figure 7). End-point titer
determinations at 24 h, 48 h and 72 h pi obtained after
infection at MOI of 0.01, 0.1 and 3 showed highest titers
when we infected at an MOI of 0.1 and again proved
that the growth characteristics of vBRf and vBR were
virtually indistinguishable from those of wild-type virus
CPXV.BR. Finally, the plaque morphology and plaque
areas determined for the three viruses were highly simi-
lar and not significantly different from each other (vBRf
vs. CPXV.BR: p = 0.7409, vBR vs. CPXV.BR: p = 0.6688,
n = 40; Figure 7). From the data of the virus growth
kinetics and plaque area comparisons we concluded that
manipulation of CPXV.BR by insertion of the mini-F
sequences and/or deletion of the TK gene did not have
a measurable effect on virus replication in Vero cells.
Hence, the TK gene of CPXV.BR is completely dispen-
sable for growth in cultured Vero cells and CPXV
reconstituted from cloned BAC DNA behaves virtually
identical to its parental wild-type virus in the culture
system examined.
Discussion
We here describe the first BAC clone containing the
complete genomic sequence of CPXV.BR. Furthermore
we report an infectious clone in which bacterial
Figure 7 Characterization of growth properties of vBRf, vBR in comparison to wild-type virus CPXV.BR. A. Vero cells were infected at the
indicated MOI (0.01 or 3) with the various viruses, and virus titers were determined from culture supernatants or the infected-cell pellets at the
time points given. Shown are means of two independent experiments and the standard deviations (error bars). B. Plaque areas were determined
by measuring a total of 40 plaques induced by each virus at 72 h pi. Plaques were stained with crystal violet and plaque images were taken
using the Axiovert 25 microscope and CCD camera (Zeiss). Plaque sizes were measured using ImageJ. Mean plaque sizes induced by CPXV.BR
were calculated and set to a 100%. Plaque areas determined for vBRf or vBR are shown relative to the CPXV.BR value. Shown are means and
standard deviations (error bars) for each virus. C. End point titers were determined after infection of Vero cells with the indicated viruses at an
MOI of 0.01, 0.1 or 3. Virus titers were determined from whole cell lysates at 24, 48 or 72 h pi.
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in eukaryotic cells and therefore present a BAC that,
upon reconstitution in cell culture, does not contain any
vector or marker sequences and therefore is genetically
indistinguishable from the parental virus.
For generation of the infectious clone, the thymidine
kinase locus was chosen based on data from other
orthopox viruses, which had shown the nonessential nat-
ure of the gene when virus is propagated in cultured cells
[20]. Our results on the generation of a TK-negative
CPXV.BR virus, achieved through the insertion of bacter-
ial vector sequences into the TK locus, lend support to
the non-essential function of this gene in CPXV. Further-
more, detailed analysis of the growth characteristics
showed that even vBRf, in which the TK is disrupted by
the 9 kbp insertion of the mini-F vector, does not behave
differently from parental, wild-type BR.
Despite the unaltered growth properties and the fact
that use of GFP-expressing recombinant CPXV.BR is
very useful for some applications, we further sought to
develop the infectious clone in a fashion that would ren-
der the geno- and phenotype of viruses reconstituted
from the infectious clone absolutely identical to that of
parental CPXV.BR. We previously reported that loss
of vector sequences is made possible by the occurrence
of two antiparallel recombination events mediated by a
sequence duplication within mini-F vector sequences
[10]. Such recombination in the case of transfection of
pBR indeed led to self-excision of the mini-F cassette
upon vBR reconstitution, which was shown by the loss
of sequences coding for GFP and was confirmed not
only by the absence of autofluorescence but also by
PCR, RFLP and Southern blotting of virus progeny
resulting from pBR transfection.
Genetic identity of the generated CPXV.BAC was pro-
ven by RFLP, Southern blot analyses and finally pyrose-
quencing of the entire cloned genome. Parts of the
inverted terminal repeat regions (nt positions 0-2 546
and 232 280-234 825) could not be analyzed due to the
high content of A and T rich repeats and the highly repe-
titive character of the sequences. Remaining sequence
differences between the generated BAC and the pub-
lished sequence available for BR (genbank_acces-
sion#NC_003663) were shown to be caused by
alterations already present in the parental wild-type
CPXV.BR used for cloning or representing errors that
occurred following PCR amplification of the TK flanks.
Our sequencing results indicate that CPXV.BR isolates
differ minimally in their genetic material, an alternative
explanation remaining that sequencing errors account for
the discrepancies. However, all sequence modifications
are located within the less conserved terminal part of the
genome, where higher mutation rates due to host-patho-
gen co-evolutionary events are expected and frequently
seen [21]. The fact that congruence was observed regard-
ing the phenotype in vitro was shown by observing pla-
que sizes and growth kinetics suggests that both
generated BAC clones after reconstitution in cultured
cells in fact behave in a fashion that is practically identi-
cal to that of wild-type virus and present a number of
advantages. pBRf, expressing GFP under a poxvirus pro-
moter, produces labeled virus after reconstitution and
mutants can easily be tracked by fluorescence micro-
scopy, whilst pBR results in a virus that does not contain
any foreign sequences. Therefore, if one generates
mutant genomes based on pBR, only the desired muta-
tion will be present and otherwise represent a wild-type
background, which will exclude unintended side effects
by marker sequences especially in in vivo experiments.
In summary, both BAC clones presented here enable the
use of fast and easy bacterial mutagenesis methods for the
generation of cowpox virus mutants. In our initial muta-
genesis attempts of pBR and pBRf, we observed genomic
stability as was shown for the other available orthopox-
virus full-length DNA clones. Therefore, the CPXV.BR
BAC represents a toolbox that will simplify pathogenesis
studies of a recently emerging virus not only relevant to
several species of animals but also exhibiting zoonotic
potential. Other members of the family Poxviridae have
already proven to show excellent performance as vectors
for vaccination or gene therapy purposes, applications that
are greatly simplified by the use of cloned viral genomes
such as the CPXV BAC generated here.
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